Gregory Fraser

Stock Analyst at Truist Securities

(2.67)
# 2,202
Out of 5,043 analysts
39
Total ratings
57.14%
Success rate
15.45%
Average return

Stocks Rated by Gregory Fraser

ANI Pharmaceuticals
Oct 9, 2025
Maintains: Hold
Price Target: $77$90
Current: $92.83
Upside: -3.05%
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $200$205
Current: $138.84
Upside: +47.65%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8$7
Current: $6.15
Upside: +13.91%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200$160
Current: $2.10
Upside: +7,519.05%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10$9
Current: $2.75
Upside: +227.27%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6$7
Current: $10.30
Upside: -32.04%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26$29
Current: $71.05
Upside: -59.18%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $13.42
Upside: +607.90%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14$18
Current: $7.00
Upside: +157.14%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45$40
Current: $24.95
Upside: +60.32%